MedPath

Phase II trial of Transcatheter arterial micro-embolization for refractory chronic hip pain: Multicenter Study (REACH study)

Phase 2
Conditions
Chronic hip pain refractory to non-surgical management due to mild osteoarthritis
Registration Number
JPRN-UMIN000027219
Lead Sponsor
Miyakojima IGRT clinic
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Complete: follow-up complete
Sex
All
Target Recruitment
20
Inclusion Criteria

Not provided

Exclusion Criteria

1.Surgical candidate 2.Patients with severe infection, rheumatoid arthritis, or mental disorder 3.Patients with uncontrollable diabetic mellitus 4.Pain due to spine pathology 5.Patients with osteonecrosis with magnetic resonance imaging (MRI) 6.Patients without possibility of going to hospital and follow up for 6 months. 7.Patient who was decided not to be appropriate for this trial by physician

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
umerical Rating Scale (NRS) in 6 months after procedure Oxford Hip score in 6 months after procedure Quality of Life(QOL) in 6 months after procedure
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath